PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GlycoScientific, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GlycoScientific Introduces A Stable Isotope Labeled Monoclonal Antibody - iGlycoMab™ - GlycoScientific introduces a stable isotope labeled monoclonal antibody (mAb) (iGlycoMab™) to facilitate the accurate and precise quantitative glycan profiling of biological therapeutics, particularly monoclonal antibodies and fusion proteins
GlycoScientific Introduces A Stable Isotope Labeled Monoclonal Antibody - iGlycoMab™

 

NewswireToday - /newswire/ - Athens, GA, United States, 2015/05/28 - GlycoScientific introduces a stable isotope labeled monoclonal antibody (mAb) (iGlycoMab™) to facilitate the accurate and precise quantitative glycan profiling of biological therapeutics, particularly monoclonal antibodies and fusion proteins.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

GlycoScientific Raises the Accuracy and Precision Standard for Glycan Quantitation

GlycoScientific is pleased to introduce iGlycoMab™, a monoclonal antibody (mAb) whose glycans are labeled with a stable isotope. This product is designed to offer the glycobiology community the accuracy and precision provided by an isotopically labeled standard, and will be highlighted by various presentations at the 2015 American Society for Mass Spectrometry (ASMS) conference.1

iGlycoMab™ is designed to facilitate quantitative glycan profiling of biological therapeutics, particularly monoclonal antibodies and fusion proteins. However, iGlycoMab™ can be applied to individual glycans or complex mixtures such as those observed in the field of glycomics. “We envision that the combination of isotopically labeled glycan with LC-MS analysis will become the new gold standard from glycan quantification” states Ron Orlando, a GlycoScientific founder.

“The use of 15N labeled N-glycans derived from IGG has alleviated quantitative MS-based glycomics variabilities originating from PNGase F digestion efficiency, chemical derivatization and ionization efficiency,” states Yehia Mechref Professor in the Department of Chemistry and Biochemistry, Texas Tech University. This enables dramatic improvement of the accuracy and precision compared to other approaches and does not require modification of user’s methodology. In addition, iGlycoMab™ can be directly incorporated into mass spectrometric glycan/glycomic workflows, enabling reliable quantitative results to be obtained from qualitative discovery experiments. Furthermore, because “like molecules” will experience similar biases during the sample preparation and measurement the use of a labeled mAb is ideal for the analysis of other mAbs.

The originality and overall benefit to the scientific community were attributes that garnered an outstanding scientific presentation award at the 2015 conference of the Association of Biomolecular Resource Facilities.

iGlycoMab™ can be purchased online.

About GlycoScientific

GlycoScientific, LLC is a privately-held company engaged in the development and commercialization of unique research reagents in the field of glycobiology, including development of products that involve characterization of glycosylation. The company is based in Athens, Georgia, next door to the University of Georgia’s Complex Carbohydrate Research Center. The company is backed by a team that is embedded in many relevant disciplines, including proteomics, glycomics, liquid chromatography and mass spectrometry of glycans and glycoproteins. GlycoScientific has received funding from the National Institutes of Health and private sources, including the Georgia Research Alliance. For more information, please visit glycoscientific.com.

iGlycoMab is a trademark of GlycoScientific, LLC.
1iGlycoMab™ will be highlighted in ASMS presentations MP 682 and WOD am 9:50.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GlycoScientific, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


GlycoScientific Introduces A Stable Isotope Labeled Monoclonal Antibody - iGlycoMab™

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Ron Orlando - GlycoScientific.com 
706-286-8787 ronorlando[.]glycoscientific.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GlycoScientific, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GlycoScientific, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  S&A Capital Partner Ltd

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)